Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/04/2010US20100056537 Pharmaceutical composition having relatively low ionic strength
03/04/2010US20100056536 Method of treating atrial fibrillation
03/04/2010US20100056535 Inhibitors of HIV-1 reverse transcriptase
03/04/2010US20100056533 18f-labelled folates
03/04/2010US20100056532 Compounds that modulate intracellular calcium
03/04/2010US20100056531 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
03/04/2010US20100056530 Glucokinase activators
03/04/2010US20100056529 Substituted triazolo-pyridazine derivatives
03/04/2010US20100056528 Sulfonamide derivatives with therapeutic indications
03/04/2010US20100056527 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
03/04/2010US20100056526 3-(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's diseas
03/04/2010US20100056525 5- and 6- substituted benzimidazole thiophene compounds
03/04/2010US20100056524 Compound
03/04/2010US20100056523 Inhibitors of akt activity
03/04/2010US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient
03/04/2010US20100056521 (aza)indole derivative and use thereof for medical purposes
03/04/2010US20100056520 Formulations of phospholipase enzyme inhibitors
03/04/2010US20100056519 Composition and method for reducing platelet activation and for the treatment of thrombotic events
03/04/2010US20100056518 Cycloalkylamine substituted isoquinolone derivatives
03/04/2010US20100056517 Arylsulfonamide compounds
03/04/2010US20100056516 1-hydroxy naphthyridine compounds as anti-hiv agents
03/04/2010US20100056515 Benzimidazole compounds
03/04/2010US20100056514 Thienopyrazoles
03/04/2010US20100056513 Stereospecifically substituted benzo[1,3]dioxolyl derivatives
03/04/2010US20100056512 Pyrimidine compounds
03/04/2010US20100056511 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents
03/04/2010US20100056510 Macrocyclic Compound
03/04/2010US20100056509 Heteroaryl sulfonamides and ccr2
03/04/2010US20100056508 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056505 Substituted Pyrazalones
03/04/2010US20100056504 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester- introduced phenyl group as substituents
03/04/2010US20100056503 Compounds for modulating integrin CD11b/CD18
03/04/2010US20100056502 Compounds
03/04/2010US20100056501 Substituted lactams as inhibitors of abeta protein production
03/04/2010US20100056500 Stable Parenteral Formulation
03/04/2010US20100056499 3-amino-1-arylpropyl azaindoles and uses thereof
03/04/2010US20100056498 Substituted monocyclic cgrp receptor antagonists
03/04/2010US20100056497 Amide derivative
03/04/2010US20100056496 Muscarinic receptor antagonists
03/04/2010US20100056495 Dimeric iap inhibitors
03/04/2010US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
03/04/2010US20100056493 Modified release pharmaceutical composition and a process of making the same
03/04/2010US20100056492 Compounds and uses thereof - 152
03/04/2010US20100056491 4'-amino cyclic compounds having 5-ht6 receptor affinity
03/04/2010US20100056490 Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
03/04/2010US20100056489 Treatment of neuropathic pain
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100056487 Modulators of amyloid-beta production
03/04/2010US20100056486 Combinations comprising antimuscarinic agents and corticosteroids
03/04/2010US20100056485 Nanosoap containing silver nanoparticles
03/04/2010US20100056484 Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress
03/04/2010US20100056483 Methods and compositions for the treatment and prevention of bone loss
03/04/2010US20100056482 Calixarene Derivatives as Anticancer Agent
03/04/2010US20100056481 Crystalline forms of zoledronic acid
03/04/2010US20100056480 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
03/04/2010US20100056478 Useful Combinations of Monobactam Antibiotics With Beta-Lactamase Inhibitors
03/04/2010US20100056476 Pharmaceutical compositions comprising peranhydrocyclodextrin
03/04/2010US20100056475 Cyclodextrin conjugates
03/04/2010US20100056474 Methods and Compositions for the Prevention of and Treatment of Infections Utilizing Chitosan-Derivative Compounds
03/04/2010US20100056473 Method of extracting fucoidan
03/04/2010US20100056472 Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same
03/04/2010US20100056471 Semi-fluid food product comprising beta-glucan fibres
03/04/2010US20100056470 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions
03/04/2010US20100056468 Pyrimidine Derivatives As Anticancer Agents
03/04/2010US20100056467 Combination of iap inhibitors and flt3 inhibitors
03/04/2010US20100056466 2'-Cyanopyrimidine Nucleoside Compound
03/04/2010US20100056465 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056464 Compounds, compositions and methods of using same for modulating uric acid levels
03/04/2010US20100056463 Novel compositions
03/04/2010US20100056462 Medical composition for promotion of skin regeneration
03/04/2010US20100056457 Zinc Finger Binding Domains for CNN
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100056445 Adiponectin for the treatment and diagnosis of albuminuria
03/04/2010US20100056444 Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
03/04/2010US20100056426 Use of iron chelator for the treatment of myocardial infarction
03/04/2010US20100056425 Absorption enhancers such as E.G. BHT, BHA or propyl gallate
03/04/2010US20100055744 Dna mini-circles and uses thereof
03/04/2010US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571
03/04/2010US20100055209 Standardized Extract And Its Use In The Manufacture Of A Medicament
03/04/2010US20100055207 Methods of making and using a liquid concentrate thickener
03/04/2010US20100055206 Use of ribose in first response to acute myocardial infarction
03/04/2010US20100055205 Functional consumable compositions for promoting skin health and methods for using the same
03/04/2010US20100055201 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
03/04/2010US20100055196 Sanitizing composition
03/04/2010US20100055193 Stable powder formulation containing an anticholinergic agent
03/04/2010US20100055192 Micronized particles of low-dosage strength active agents for powder formulations for inhalation
03/04/2010US20100055190 Sterol-Containing Compositions
03/04/2010US20100055189 Nanoparticles for immunotherapy
03/04/2010US20100055185 Composition and method for treating hemorrhoids and/or anorectal disorders
03/04/2010US20100055184 Hydrogels for vocal cord and soft tissue augmentation and repair
03/04/2010US20100055183 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010US20100055182 Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health
03/04/2010US20100055181 Controlled release dosage forms of zolpidem
03/04/2010US20100055180 Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
03/04/2010US20100055178 Enteric-coated creatine compositions and methods of use thereof
03/04/2010US20100055177 Modified release composition of levetiracetam and process for the preparation thereof
03/04/2010US20100055176 Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
03/04/2010US20100055173 Release of statins in the intestine
1 ... 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 ... 7860